Med Sci (Paris)
Volume 25, Number 8-9, Août-Septembre 2009
Accidents vasculaires cérébraux
Page(s) 733 - 738
Section M/S revues : Accidents vasculaires cérébraux (1)
Published online 15 August 2009
  1. Hankey GJ, Warlow CP. Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations. Lancet 1999; 354 : 1457–63. [Google Scholar]
  2. Guidelines for management of ischaemic stroke and transient ischaemic attack. Cerebrovasc Dis 2008; 25 : 457–507. [Google Scholar]
  3. Langhorne P, Dennis MS. Stroke units, an evidence based approach. London : BMJ Publishing Group, 1998. [Google Scholar]
  4. Indredavik B, Bakke F, Slordahl SA, et al. Stroke unit treatment. 10-year follow-up. Stroke 1999; 30 : 1524–7. [Google Scholar]
  5. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363 : 768–74. [Google Scholar]
  6. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359 : 1317–29. [Google Scholar]
  7. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of thrombolysis in stroke-monitoring study (SITS-MOST): an observational study. Lancet 2007; 369 : 275–82. [Google Scholar]
  8. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 2008; 372 : 1303–9. [Google Scholar]
  9. CAST. Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese acute stroke trial) Collaborative Group. Lancet 1997; 349 : 1641–9. [Google Scholar]
  10. International-Stroke-Trial-Collaborative-Group. The International Stroke Trial (IST): a randomised trial if aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 1997; 349 : 1569–81. [Google Scholar]
  11. Bath PM, Iddenden R, Bath FJ. Low-molecular-weight heparins and heparinoids in acute ischemic stroke: a meta-analysis of randomized controlled trials. Stroke 2000; 31 : 1770–8. [Google Scholar]
  12. Bath PM, Lindenstrom E, Boysen G, et al. Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial. Lancet 2001; 358 : 702–10. [Google Scholar]
  13. Berge E, Abdelnoor M, Nakstad PH, Sandset PM. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial. Lancet 2000; 355 : 1205–10. [Google Scholar]
  14. Vahedi K, Hofmeijer J, Jüttler E, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 2007; 6 : 215–22. [Google Scholar]
  15. Anderson CS, Huang Y, Wang JG, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol 2008; 7 : 391–9. [Google Scholar]
  16. Steiner T, Kaste M, Forsting M, et al. Recommendations for the management of intracranial haemorrhage. Part I: spontaneous intracerebral haemorrhage. The European stroke initiative writing committee and the writing committee for the EUSI executive committee. Cerebrovasc Dis 2006; 22 : 294–316. [Google Scholar]
  17. Mendelow AD, Gregson BA, Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International surgical trial in intracerebral haemorrhage (STICH): a randomised trial. Lancet 2005; 365 : 387–97. [Google Scholar]
  18. Mayer SA, Brun NC, Begtrup K, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005; 352 : 777–85. [Google Scholar]
  19. Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008; 358 :2127–37. [Google Scholar]
  20. PROGRESS collaborative group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358 : 1033–41. [Google Scholar]
  21. Amarenco P, Bogousslavsky J, Callahan A, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355 : 549–59. [Google Scholar]
  22. Algra A, van Gijn J. Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin. J Neurol Neurosurg Psychiatry 1999; 66 : 255. [Google Scholar]
  23. CAPRIE Steering Committee. A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348 : 1329–39. [Google Scholar]
  24. Algra A. Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial. Lancet Neurol 2007; 6 : 115–24. [Google Scholar]
  25. Sacco RL, Diener HC, Yusuf S, et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 2008; 359 : 1238–51. [Google Scholar]
  26. Diener H, Bogousslavsky J, Brass L, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004; 364 : 331–7. [Google Scholar]
  27. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993; 342 : 1255–62. [Google Scholar]
  28. The North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American symptomatic carotid endarterectomy trial collaborators. N Engl J Med 1991; 325 : 445–53. [Google Scholar]
  29. The European Carotid Surgery Trialists Collaborative Group. Risk of stroke in the distribution of an asymptomatic carotid artery. Lancet 1995; 345 : 209–12. [Google Scholar]
  30. Rothwell P, Eliasziw M, Gutnikov S, et al., for the Carotid Endarterectomy Trialists Collaboration. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004; 363 : 915–24. [Google Scholar]
  31. Mas JL, Chatellier G, Beyssen B, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006; 355 : 1660–71. [Google Scholar]
  32. Mas JL, Trinquart L, Leys D, et al. Endarterectomy versus angioplasty in patients with symptomatic severe carotid stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial. Lancet Neurol 2008; 7 : 885–92. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.